Androgen Production Continues in Prostate Cancer Tumors, Fred Hutchinson Cancer Research Center Study Finds

HealthDay News -- U.S. researchers have uncovered new information about how metastatic prostate cancer becomes resistant to androgen-deprivation therapy, which suppresses circulating testosterone, the hormone that promotes prostate cancer growth.

Back to news